Recent data showed that CD44 might exist in different variants, playing a distinct biological role in cells, but only its variant, CD44v3, is overexpressed in CSCs and is related to HNSCC progression [86,91]. This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.